Abstract

Este estudo analisou as inovações no tratamento da dor crônica associada à neuropatia diabética por meio de uma revisão de escopo, seguindo as recomendações do Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). As opções de farmacoterapia de primeira linha incluem antidepressivos duais e tricíclicos, além de anticonvulsivantes gabapentinoides. Entre as terapias não farmacológicas, pode-se destacar a estimulação nervosa elétrica transcutânea (TENS) e técnicas de agulhamento.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.